Table 3.
Clinical correlates of GDF-15 in 2,991 FHS participants
Clinical Characteristic | estimated coefficient |
s.e. | P Value |
---|---|---|---|
Age, per 10 years | 0.211 | 0.006 | <0.0001 |
Sex, men vs women | 0.006 | 0.013 | 0.64 |
Diabetes, yes vs no | 0.142 | 0.020 | <0.0001 |
Hypertension treatment, yes vs no | 0.073 | 0.014 | <0.0001 |
Smoking, yes vs no | 0.220 | 0.016 | <0.0001 |
Total cholesterol, per 38 mg/dl | −0.028 | 0.006 | <0.0001 |
HDL cholesterol, per 16 mg/dl | −0.024 | 0.007 | 0.0003 |
eGFR, per 42 ml/min/1.73m2 | −0.032 | 0.006 | <0.0001 |
NSAID use, yes vs no | 0.050 | 0.018 | 0.006 |
The regression coefficients indicate the increase in log-GDF-15 in the presence vs absence of the trait for dichotomous variables, and per 1 standard deviation increase as noted in continuous variables. The following variables were not significant in the forward selection model (P > 0.05): systolic blood pressure, body-mass index, left ventricular hypertrophy, and atrial fibrillation.
s.e., standard error; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; NSAID, non-steroidal anti-inflammatory drug;